Key result
Multidisciplinary management including endovascular removal of recurrent IVC tumor followed by pulmonary bilobectomy resulted in the patient remaining without evidence of recurrent disease.
Why the study?
Renal cell carcinoma recurrence within the vasculature is a rare and challenging clinical scenario with limited evidence to guide management.
Case Report (n=1)
This case highlights the feasibility and potential role of minimally invasive endovascular techniques in managing complex intravascular recurrence of renal cell carcinoma.
Answers are grounded in this paper and cite their sources.
May support endovascular options for recurrent vascular RCC; leaves open safety and efficacy pending prospective data.
Renal cell carcinoma (RCC) recurrence within the vasculature represents a rare and challenging clinical scenario with limited evidence to guide management. We report a patient with clear cell RCC and level 4 IVC thrombus who underwent successful radical nephrectomy with IVC thrombectomy and subsequently developed disease recurrence in the supradiaphragmatic IVC and pulmonary arteries. Multidisciplinary management included novel endovascular removal of the recurrent IVC tumor followed by pulmonary bilobectomy for progressive tumor emboli. The patient remains without evidence of recurrent disease. This case highlights the complex multidisciplinary decision-making and potential role of minimally invasive endovascular techniques in managing intravascular RCC.
No takes yet. Share an insight, caveat, or question.
Temple et al. (2026) conducted a case report in Renal cell carcinoma with intravascular recurrence (n=1). Endovascular removal of recurrent IVC tumor and pulmonary bilobectomy was evaluated on Disease recurrence. Multidisciplinary management including endovascular removal of recurrent IVC tumor followed by pulmonary bilobectomy resulted in the patient remaining without evidence of recurrent disease.
Synapse has enriched 10 related papers. Consider them for comparative context: